Publications by authors named "R L Summitt"
Background: CrossFit, a sport and fitness program, has become increasingly popular both nationally and internationally. Researchers have recently identified significant improvements in health and wellness due to CrossFit. However, some individuals assert that CrossFit poses an inherent risk of injury, specifically to the shoulder, due to the intensity of training.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to compare the resource use outcomes between two treatment options for women with abnormal uterine bleeding: expanded medical treatment and hysterectomy.
- Results showed that women who underwent hysterectomy incurred higher costs ($6,777) compared to those on medical treatment ($4,479), largely due to the surgical procedure itself.
- The conclusion indicates that while hysterectomy leads to higher resource use, it also provides better clinical results and quality-of-life outcomes within six months compared to expanded medical treatment.
Objective: To compare sexual functioning and health-related quality-of-life outcomes of total abdominal hysterectomy (TAH) and supracervical hysterectomy (SCH) among women with symptomatic uterine leiomyomata or abnormal uterine bleeding refractory to hormonal management.
Methods: We randomly assigned 135 women scheduled to undergo abdominal hysterectomy in 4 U.S.
Objective: Hysterectomy is the most common major surgical procedure performed in the United States for nonobstetric reasons. Although most hysterectomies include removal of the cervix, the rate of supracervical procedures has increased in recent years. To provide evidence about the outcomes of both types of hysterectomy, we conducted a randomized clinical trial of total (TAH) or supracervical (SCH) hysterectomy (the "TOSH" trial).
View Article and Find Full Text PDFObjective: To compare clinical outcomes after randomization to hysterectomy versus medical treatment in patients with chronic abnormal uterine bleeding refractory to medroxyprogesterone acetate.
Methods: We randomly assigned 63 premenopausal women with abnormal uterine bleeding refractory to cyclic medroxyprogesterone acetate treatment to receive either a hysterectomy or expanded medical treatment. Within each randomized group, the specific treatment approach was determined by patient and provider preference.